Chemoinformaics analysis of Cynarotrioside
Molecular Weight | 756.663 | nRot | 9 |
Heavy Atom Molecular Weight | 716.343 | nRig | 36 |
Exact Molecular Weight | 756.211 | nRing | 6 |
Solubility: LogS | -2.984 | nHRing | 4 |
Solubility: LogP | -1.522 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 93 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 53 | No. of Aromatic Carbocycles | 2 |
nHetero | 20 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 3 |
No. of Carbon atom | 33 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 20 | No. of Arom Bond | 17 |
nHA | 20 | APOL | 97.8217 |
nHD | 12 | BPOL | 53.1483 |
QED | 0.099 |
Synth | 5.338 |
Natural Product Likeliness | 1.628 |
NR-PPAR-gamma | 0.898 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.992 |
HIA | 0.995 |
CACO-2 | -6.368 |
MDCK | 0.000222669 |
BBB | 0.395 |
PPB | 0.674857 |
VDSS | 0.51 |
FU | 0.243118 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.013 |
CYP2c19-inh | 0.003 |
CYP2c19-sub | 0.055 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.146 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.143 |
CYP3a4-inh | 0.003 |
CYP3a4-sub | 0.001 |
CL | 1.17 |
T12 | 0.191 |
hERG | 0.032 |
Ames | 0.352 |
ROA | 0.02 |
SkinSen | 0.006 |
Carcinogencity | 0.452 |
EI | 0.004 |
Respiratory | 0.009 |
NR-Aromatase | 0.893 |
Antiviral | Yes |
Prediction | 0.745711 |